1Patício P,Ferreira C,Comes MM,et al.Autoimmune bullous dermatoses:a review[J].Ann N Y Acad Sci,2009,1173:203-210.
2Navi D,Michael DJ,Fazel N.Drug-induced linear IgA hullous dermatosis[J].Dermatol Online J,2006,12(5):12.
3Mul VE,van Geest AJ,Pijls-Johannesma MC,et al.Radiation-induced bullous pemphigoid:A systematic review of an unusual radiation side effect[J].Radiotherapy and Ontology,2007,82(1):5-9.
4Guide SV,Marinkovich MP.Linear IgA bullous dermatosis[J].Clin Dermatol,2001,19(6):719-727.
5Usmani N,Baxter KF,Child JA,et al.Linear IgA disease in association with chronic lymphocytic leukaemia[J].Br,J Dermatol,2004,151(3):710-711.
6Green ST,Natarajan S.Linear IgA disease and oesophageal carcinoma[J].R Soc Med,1987,80(1):48-49.
7van der Waal RI,van de Scheur MR,Pas HH,et al.Linear IgA bullous dermatosis in a patient with renal cell carcinoma[J].Br J Dermatol,2001,144(4):870-873.
8Dauendorffer JN,Muhé E,Saiag P.Tacrolimus ointment,an interesting adjunctive therapy for childhood linear IgA bullous dermatosis[J].J Eur Acad Dermatol Venereol,2008,22(3):364-365.
5Burman KD, McKinley-Grant L. Dermatologic aspects of thyroid disease[J]. Clin Dermatol, 2006, 24(4): 247-255.
6Wojnarowska F, Marsden RA, Bhogal B, et al. Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear lgA disease of adults. A comparative study demonstraling clinical and immunopathologic overlap[ J ]. J Am Acad Dermatol, 1988, 19 (5) : 792 - 805.
7Mascanfroni ID, Montesinos Mdel M, Alamino VA, et al. Nuclear factor ( NF)-kappaB-dependent thyroid hormone receptor beta1 expression controls dendritic cell function via Akt signaling[ J ]. J Biol Chem, 2010, 285(13) : 9569 -9582.
8Wu R. Li R. Propylthiouracil-induced autoimmune syndromes 11 case report[J].Rtheumatol Int, 2010, 7 [ Epub ahead of print ].
